{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:59:26Z","timestamp":1778047166188,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.pdpdt.2021.102453","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T19:25:16Z","timestamp":1626895516000},"page":"102453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-term prognosis of polypoidal choroidal vasculopathy with a 5-year remission after an initial combination therapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Wataru","family":"Kikushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Sakurada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seigo","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mio","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102453_bib0002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajo.2007.03.047","article-title":"Clinical characteristics of exudative age-related macular degeneration in Japanese patients","volume":"144","author":"Maruko","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.pdpdt.2021.102453_bib0004","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s004170000180","article-title":"Polypoidal choroidal vasculopathy in Caucasians","volume":"238","author":"Lafaut","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.pdpdt.2021.102453_bib0005","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0002-9394(03)01147-4","article-title":"Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy","volume":"137","author":"Nishijima","year":"2004","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102453_bib0006","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.ophtha.2003.12.056","article-title":"Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series","volume":"111","author":"Chan","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0007","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/bjo.2007.122283","article-title":"Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"92","author":"Gomi","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.pdpdt.2021.102453_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2009.12.038","article-title":"Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for polypoidal choroidal vasculopathy","volume":"149","author":"Sato","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0009","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10384-016-0479-4","article-title":"Retreatment of polypoidal choroidal vasculopathy after photodynamic therapy combined with intravitreal ranibizumab","volume":"61","author":"Kikushima","year":"2017","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.pdpdt.2021.102453_bib0010","article-title":"Five-year visual outcomes after anti-VEGF therapy with or without photodynamic therapy for polypoidal choroidal vasculopathy","author":"Miyata","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12886-019-1245-4","article-title":"Five-year real-world outcomes of anti-vascular endothelial growth factor monotherapy versus combination therapy for polypoidal choroidal vasculopathy in a Chinese population: a retrospective study","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102453_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237330","article-title":"Response to photodynamic therapy combined with intravitreal aflibercept for polypoidal choroidal vasculopathy depending on fellow-eye condition:2-year results","volume":"15","author":"Matsubara","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0013","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1038\/s41598-019-48494-6","article-title":"Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration","volume":"9","author":"Fukuda","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.pdpdt.2021.102453_bib0014","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1609717","article-title":"Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy","volume":"2019","author":"Yang","year":"2019","journal-title":"J Ophthalmol"},{"issue":"8","key":"10.1016\/j.pdpdt.2021.102453_bib0015","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4103\/ijo.IJO_1222_17","article-title":"Long-term efficacy and safety of verteporfin photodynamic therapy in combination with anti-vascular endothelial growth factor for polypoidal choroidal vasculopathy","volume":"66","author":"Jain","year":"2018","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.pdpdt.2021.102453_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229231","article-title":"Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"15","author":"Wataru","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102453_bib0017","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1097\/IAE.0b013e3181e587e3","article-title":"Association of LOC387715 A69S genotype with visual prognosis after photodynamic therapy for polypoidal choroidal vasculopathy","volume":"30","author":"Sakurada","year":"2010","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0018","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000480439","article-title":"Retreatment of Exudative Age-Related Macular Degeneration after Loading 3-Monthly Intravitreal Ranibizumab","volume":"239","author":"Sugiyama","year":"2018","journal-title":"Ophthalmologica"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0019","doi-asserted-by":"crossref","first-page":"16461","DOI":"10.1038\/s41598-017-16476-1","article-title":"Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy","volume":"7","author":"Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.pdpdt.2021.102453_bib0020","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1097\/IAE.0000000000001427","article-title":"Choroidal Thickness as a Prognostic Factor of Photodynamic Therapy with Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy","volume":"37","author":"Sakurada","year":"2017","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0021","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1038\/s41598-017-09632-0","article-title":"A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration","volume":"7","author":"Yamashiro","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.pdpdt.2021.102453_bib0022","doi-asserted-by":"crossref","first-page":"44020","DOI":"10.1038\/srep44020","article-title":"Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration","volume":"7","author":"Kikushima","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.pdpdt.2021.102453_bib0023","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10384-019-00683-6","article-title":"Association of an age-related maculopathy susceptibility 2 gene variant with the 12-month outcomes of intravitreal aflibercept combined with photodynamic therapy for polypoidal choroidal vasculopathy","volume":"63","author":"Nakai","year":"2019","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"10.1016\/j.pdpdt.2021.102453_bib0024","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1038\/s41598-020-64301-z","article-title":"Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy","volume":"10","author":"Yoneyama","year":"2020","journal-title":"Sci Rep"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100021002775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:43:54Z","timestamp":1761612234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100021002775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":24,"alternative-id":["S1572100021002775"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102453","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term prognosis of polypoidal choroidal vasculopathy with a 5-year remission after an initial combination therapy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2021.102453","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102453"}}